MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings ROE Ratio 2011-2026 | ONVO
Annual ROE Ratio Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -23.71 | -4030.49 | -112.59 | -42.93 | -70.26 | -73.38 | -78.06 | -61.65 | -62.04 | -61.78 | -53.53 | -179.71 | 821.29 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 821.29 | -4030.49 | -309.91 |
Quarterly ROE Ratio Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1073.4 | -1959.79 | -1993.03 | -1066.44 | -1124.74 | -236.06 | -214.02 | -139.74 | -154.38 | -110.73 | -76.77 | -39.55 | -50.74 | -47.28 | -61.88 | -45.85 | -52.31 | -53.22 | -37.91 | -67.23 | -71.17 | -70.71 | -68.99 | -50.3 | -57.32 | -63.62 | -69.24 | -65.93 | -65.22 | -63.31 | -65.03 | -68.55 | -68.93 | -66.42 | -66.5 | -66.07 | -63.08 | -64.71 | -60.19 | -56.17 | -59.5 | -58.84 | -58.19 | -65.22 | -61.1 | -57.32 | -81.52 | -266.24 | -432.64 | -241.6 | -82.27 | 943.95 | 1822.93 | 1644.95 | 1761.93 | 944.3 | 484.08 | 239.03 | 3.65 | 239.03 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1822.93 | -1993.03 | -54.62 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.08 | 1.7 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.38 | 1.16 % | $ 323 M | Israel |
 |
DexCom
DXCM
|
30.46 | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 103.65 | -1.16 % | $ 4.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 211.14 | -1.74 % | $ 154 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 23.24 | 1.18 % | $ 703 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
-302.3 | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
312.48 | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
63.26 | $ 12.09 | -5.81 % | $ 297 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 166.72 | -1.27 % | $ 30.2 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 204.66 | -1.53 % | $ 20.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 31.11 | -0.94 % | $ 20 B | Niderland |
|
Biodesix
BDSX
|
-205.65 | $ 11.55 | 6.6 % | $ 1.5 B | USA |
 |
Personalis
PSNL
|
-40.05 | $ 8.22 | -2.09 % | $ 487 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
60.8 | $ 23.61 | -0.55 % | $ 995 M | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Bioventus
BVS
|
-90.0 | $ 8.22 | 1.48 % | $ 515 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 429.09 | 3.14 % | $ 12.4 B | USA |